2-Amino-4-bromobenzoic acid |
2-氨基-4-溴苯甲酸 |
20776-50-5 |
tert-Butyl 3-oxoazetidine-1-carboxylate |
1-Boc-3-氮杂环丁酮 |
398489-26-4 |
PF-06928215 |
PF-06928215 |
2378173-15-8 |
Methanone, (2,6-dimethyl-4-pyridinyl)[4-[7-(trans-4-hydroxycyclohexyl)-2-[[(1S)-1-methylbutyl]amino]-7H-pyrrolo[2,3-d]pyrimidin-5-yl]-1-piperidinyl]- |
化合物 T9134 |
2226789-82-6 |
1,7-Naphthyridine-3-carboxaldehyde, 8-chloro- |
8-氯-1,7-萘啶-3-甲醛 |
1956389-95-9 |
CycLuc-12 |
化合物 T31143 |
1627696-39-2 |
N1-Acetylsulfamethoxazol |
6-氨基-D-荧光素 |
161055-47-6 |
4-ethynylcyclohexan-1-one |
4-乙炔基环己烷-1-酮 |
1549050-50-1 |
CycLuc-7 |
化合物 T31146 |
1393650-89-9 |
UNC569 |
CS-2399 |
1350547-65-7 |
Vortioxetine iMpurity |
沃替西汀杂质 |
853745-55-8 |
(2S,4R)-1-((S)-2-amino-3,3-dimethylbutanoyl)-4-hydroxy-N-((S)-1-(4-(4-methylthiazol-5-yl)phenyl)ethyl)pyrrolidine-2-carboxamide hydrochloride |
(2S,4R)-1-[(2S)-2-氨基-3,3-二甲基丁酰]-4-羟基-N-[(1S)-1-[4-(4-甲基-1,3-噻唑-5-基)苯基]乙基]吡咯烷-2-甲酰胺盐酸 |
1948273-03-7 |
UNC2250 |
反式-4-[[2-(丁基氨基)-5-[5-(4-吗啉基甲基)-2-吡啶基]-4-嘧啶基]氨基]环己醇 |
1493694-70-4 |
N-((S)-1-(4-((S)-2-(2,4-dichlorophenylsulfonaMido)-3-hydroxypropanoyl)piperazin-1-yl)-4-Methyl-1-oxopentan-2-yl)benzo[b]thiophene-2-carboxaMide |
CS-2774 |
942206-85-1 |
LDN 193189 hydrochloride |
LDN-193189 2HCL |
1435934-00-1 |
3-([1,4′-Bipiperidin]-1′-ylmethyl)-7-bromo-N-(1-phenylcyclopropyl)-2-[3-(trifluoromethyl)phenyl]-4-quinolinecarboxamide |
GSK2193874游离态 |
1336960-13-4 |
(R)-4-(3-Aminopyrrolidin-1-yl)-6-isopropylpyrimidin-2-amine |
(R)-4-(3-氨基吡咯烷-1-基)-6-异丙基嘧啶-2-胺 |
1046447-90-8 |
Methyl 2-chloro-5-fluoro-6-methylnicotinate |
2-氯-5-氟-6-甲基烟酸甲酯 |
1253383-90-2 |
Methyl 2-chloro-4-(1H-pyrazol-1-yl)benzoate |
2-氯-4-(1H-吡唑-1-基)苯甲酸甲酯 |
313674-09-8 |
LDN-193189 HCl |
LDN-193189 HCl |
1062368-62-0 |